Neurogene INC. (NGNE) SEC Filings — 2025
13 SEC filings for Neurogene INC. (NGNE) in 2025.
Filings
- Neurogene's Losses Widen Amid Increased R&D, Zero Licensing Revenue — 10-Q · Nov 13, 2025
- Neurogene Inc. Files 8-K on Nov 12, 2025 — 8-K · Nov 12, 2025
- Neurogene Inc. Files 8-K: Regulation FD & Exhibits — 8-K · Nov 6, 2025
- Neurogene Inc. Files 8-K with SEC — 8-K · Oct 9, 2025
- Neurogene's Q2 Losses Widen Amid Increased R&D Spend — 10-Q · Aug 11, 2025
- Neurogene Inc. Files 8-K with Regulatory Updates — 8-K · Jun 30, 2025
- Neurogene Inc. Announces Director Changes and Officer Compensation — 8-K · Jun 12, 2025
- Neurogene Inc. Files 8-K — 8-K · Jun 9, 2025
- Neurogene Inc. Files Q1 2025 10-Q — 10-Q · May 9, 2025
- Neurogene Inc. DEF 14A: Executive Pay & Equity Awards Detailed — DEF 14A · Apr 25, 2025
- Neurogene Inc. Files 8-K: Material Agreement, Other Events — 8-K · Apr 14, 2025
- Neurogene Inc. Files 2024 10-K — 10-K · Mar 24, 2025
- Neurogene Inc. Files 8-K with Financials and Reg FD Disclosure — 8-K · Jan 13, 2025